RESUMEN
Background: Vitamin D is essential for many functions of the body. In addition to its primary function of regulating the absorption of calcium in the small intestine, its role in the immune system has recently been studied. The current study aimed to test the impact of vitamin D deficiency on the rate of recurrent acute tonsillitis in children. Methods: According to Paradise criteria, two hundred forty-two children with recurrent acute tonsillitis were recruited. A group of healthy children (n = 262) was also recruited as controls. Poisson regression was run to predict the number of tonsillitis episodes per year based on vitamin D levels. The mean vitamin D level in the study group was lower than in the control group (p < 0.0001). Poisson regression of the rate of recurrent tonsillitis and vitamin D level (OR = 0.969 (95% CI, 0.962−0.975)) showed that for every single unit increase in vitamin D level, there was a 3.1% decrease in the number of tonsillitis episodes per year (p < 0.0001). Conclusions: Vitamin D deficiency is associated with higher rates of recurrent acute tonsillitis. Future controlled trials should investigate the role of vitamin D supplementation in reducing the rate of recurrent tonsillitis.
Asunto(s)
Absceso Peritonsilar , Trastornos Respiratorios , Tonsilitis , Deficiencia de Vitamina D , Estudios de Casos y Controles , Niño , Humanos , Jordania/epidemiología , Recurrencia , Tonsilitis/complicaciones , Tonsilitis/epidemiología , Vitamina D , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/epidemiología , VitaminasRESUMEN
In 2013, a total of 84,332 patients had undergone extracapsular tonsillectomies (TE) and 11,493 a tonsillotomy (TT) procedure in Germany. While the latter is increasingly performed, the number of the former is continually decreasing. However, a constant number of approximately 12,000 surgical procedures in terms of abscess-tonsillectomies or incision and drainage are annually performed in Germany to treat patients with a peritonsillar abscess. The purpose of this part of the clinical guideline is to provide clinicians in any setting with a clinically focused multi-disciplinary guidance through the surgical treatment options to reduce inappropriate variation in clinical care, improve clinical outcome and reduce harm. Surgical treatment options encompass intracapsular as well as extracapsular tonsil surgery and are related to three distinct entities: recurrent episodes of (1) acute tonsillitis, (2) peritonsillar abscess and (3) infectious mononucleosis. Conservative management of these entities is subject of part I of this guideline. (1) The quality of evidence for TE to resolve recurrent episodes of tonsillitis is moderate for children and low for adults. Conclusions concerning the efficacy of TE on the number of sore throat episodes per year are limited to 12 postoperative months in children and 5-6 months in adults. The impact of TE on the number of sore throat episodes per year in children is modest. Due to the heterogeneity of data, no firm conclusions on the effectiveness of TE in adults can be drawn. There is still an urgent need for further research to reliably estimate the value of TE compared to non-surgical therapy of tonsillitis/tonsillo-pharyngitis. The impact of TE on quality of life is considered as being positive, but further research is mandatory to establish appropriate inventories and standardized evaluation procedures, especially in children. In contrast to TE, TT or comparable procedures are characterized by a substantially lower postoperative morbidity in terms of pain and bleeding. Although tonsillar tissue remains along the capsule, the outcome appears not to differ from TE, at least in the pediatric population and young adults. Age and a history of tonsillitis are not a contraindication, abscess formation in the tonsillar remnants is an extremely rare finding. The volume of the tonsils should be graded according to Brodsky and a grade >1 is considered to be eligible for TT. The number of episodes during 12 months prior to presentation is crucial to indicate either TE or TT. While surgery is not indicated in patients with less than three episodes, a wait-and-see policy for 6 months is justified to include the potential of a spontaneous healing before surgery is considered. Six or more episodes appear to justify tonsil surgery. (2) Needle aspiration, incision and drainage, and abscess tonsillectomy are effective methods to treat patients with peritonsillar abscess. Compliance and ability of the patient to cooperate must be taken into account when choosing the surgical method. Simultaneous antibiotic therapy is recommended but still subject of scientific research. Abscess tonsillectomy should be preferred, if complications have occurred or if alternative therapeutic procedures had failed. Simultaneous TE of the contralateral side should only be performed when criteria for elective TE are matched or in cases of bilateral peritonsillar abscess. Needle aspiration or incision and drainage should be preferred if co-morbidities exist or an increased surgical risk or coagulation disorders are present. Recurrences of peritonsillar abscesses after needle aspiration or incision and drainage are rare. Interval TE should not be performed, the approach is not supported by contemporary clinical studies. (3) In patients with infectious mononucleosis TE should not be performed as a routine procedure for symptom control. TE is indicated in cases with clinically significant upper airway obstruction resulting from inflammatory tonsillar hyperplasia. If signs of a concomitant bacterial infection are not present, antibiotics should not be applied. Steroids may be administered for symptom relief.
Asunto(s)
Antibacterianos/uso terapéutico , Mononucleosis Infecciosa , Tonsila Palatina/patología , Absceso Peritonsilar , Tonsilectomía , Tonsilitis , Enfermedad Aguda , Adulto , Niño , Terapia Combinada , Drenaje/métodos , Alemania , Humanos , Mononucleosis Infecciosa/complicaciones , Mononucleosis Infecciosa/cirugía , Tamaño de los Órganos , Absceso Peritonsilar/etiología , Absceso Peritonsilar/cirugía , Faringitis/tratamiento farmacológico , Calidad de Vida , Prevención Secundaria/métodos , Tonsilectomía/efectos adversos , Tonsilectomía/métodos , Tonsilitis/complicaciones , Tonsilitis/diagnóstico , Tonsilitis/psicología , Tonsilitis/cirugía , Resultado del TratamientoRESUMEN
No disponible
Asunto(s)
Adulto , Femenino , Humanos , Seudotumor Cerebral , Tonsilitis/complicaciones , Tonsilitis/diagnóstico , Vacunas/efectos adversos , Vacunas/inmunología , Metilprednisolona/uso terapéutico , Tálamo/lesiones , Tálamo , Hepatitis B/inmunología , Fiebre/tratamiento farmacológico , Fiebre/etiología , Imagen por Resonancia Magnética/métodos , Espectroscopía de Resonancia Magnética/métodos , Inmunohistoquímica/métodos , Inmunohistoquímica , Diagnóstico DiferencialRESUMEN
El síndrome de Lemierre es una patología muy infrecuente en la época actual, pero muy grave, y siempre debe considerarse ante un cuadro de fiebre con antecedente de infección orofaríngea, tumefacción laterocervical a lo largo del músculo esternocleidomastoideo y signos de sepsis. El diagnóstico de este síndrome es fundamentalmente clínico, y las pruebas complementarias tan sólo ayudan a confirmar el cuadro. Presentamos el caso de un varón de 31 años que acudió a urgencias con clínica de faringoamigdalitis junto con tumefacción en la región submandibular izquierda e importante dolor cervical ipsilateral, que mostró un deterioro rápido y progresivo del estado general pese al tratamiento antibiótico intravenoso. Finalmente tuvo que ser intervenido debido al desarrollo de mediastinitis aguda necrosante descendente desde la región pretiroidea hasta el diafragma, con trombosis de la vena yugular interna izquierda. Se le realizó toracotomía urgente y cervicotomía izquierda con drenaje de abundante material purulento y ligadura de la vena yugular interna(AU)
Lemierre syndrome is a potentially fatal condition after an oropharyngeal infection. It is characterized by thrombophlebitis of head and neck veins with systemic dissemination of septic emboli. The diagnosis of this syndrome is mainly clinical and complementary test only serve as aid to confirm it. We report an unusual case of Lemierre syndrome in a 31-year-old man caused by Gemella spp. and Streptococcus pyogenes. It developed following a pharyngotonsillitis infection, which deteriorated rapidly and progressively despite intravenous antibiotic treatment. He finally had to be intervened due to developing acute descending necrotizing mediastinitis from the pre-thyroid region to the diaphragm, with thrombosis of the internal jugular vein. An urgent thoracotomy and left cervicotomy was performed, with drainage of abundant purulent material and ligature of the internal jugular vein. We also discuss its atypical clinical presentation, the crucial role of imaging in the early diagnosis, and the different treatment options of this life-threatening syndrome(AU)
Asunto(s)
Humanos , Masculino , Adulto , Trombosis de la Vena/complicaciones , Trombosis de la Vena/diagnóstico , Mediastinitis/complicaciones , Mediastinitis/diagnóstico , Tonsilitis/complicaciones , Toracotomía/métodos , Combinación Amoxicilina-Clavulanato de Potasio/uso terapéutico , Piperacilina/uso terapéutico , Daptomicina/uso terapéutico , Fluconazol/uso terapéutico , Trombosis de la Vena/cirugía , Trombosis de la Vena/terapia , Mediastinitis/fisiopatología , Mediastinitis , Infecciones por Fusobacterium/complicaciones , Fusobacterium necrophorum/aislamiento & purificación , Radiografía Torácica/métodosRESUMEN
BACKGROUND: Peritonsillar abscess (quinsy) is a complication of acute bacterial tonsillitis. Its treatment remains controversial. One element of controversy is the choice of antibiotics after surgical drainage of the abscess. Results of many studies support the resistance of grown bacteria to many antibiotics and the potential importance of anaerobic species in development of peritonsillar abscesses. AIM: The purpose of the study was to investigate bacteriology of peritonsillar abscesses in the group of own patients in an attempt to establish optimal method of antibiotic treatment after drainage of the abscess. MATERIAL AND METHODS: Abscess material from 12 patients aged 20-43 years (mean: 31.5, s.d.: 6.8), 4 women and 8 men, with peritonsillar abscesses was obtained by aspiration and sent for aerobic and anaerobic cultures. All patients were subsequently treated with oral phenoxymethylpenicillin (4.5 million units per day) and metronidazole (1500 mg per day). RESULTS: A total 18 bacterial isolates (9 anaerobic and 9 aerobic and facultative) were recovered, accounting for 1.5 isolate per specimen. Anaerobic bacteria only were present in 3 patients, aerobic and facultatives in 3, and mixed aerobic and anaerobic flora in 6. Single bacterial isolates were recovered in 6 infections. The predominant bacterial isolates were Streptococcus and Bacteroides. Recovery in all examined subjects was complete. CONCLUSIONS: In the routine management of peritonsillar abscess, bacteriologic studies are unnecessary on initial presentation. It is, however, necessary to consider infection with anaerobes, hence we recommend penicillin and metronidazole as the antibiotic regimen of choice in the treatment of peritonsillar abscesses.
Asunto(s)
Antibacterianos/uso terapéutico , Absceso Peritonsilar/tratamiento farmacológico , Absceso Peritonsilar/microbiología , Tonsilitis/complicaciones , Enfermedad Aguda , Adulto , Farmacorresistencia Bacteriana , Femenino , Humanos , Masculino , Metronidazol/uso terapéutico , Pruebas de Sensibilidad Microbiana , Penicilina V/uso terapéutico , Absceso Peritonsilar/cirugía , Tonsilitis/microbiología , Resultado del TratamientoRESUMEN
INTRODUCTION: Hearing is foundamental for human social life. Secretory Otitis Media (SOM) is the most important cause of trasmissive hypoacusis in early childhood. METHODS: The Department of Physiopathology, Experimental Medicine and Public Health of Siena University in collaboration with the Thermal Baths "Bagni delle Galleraie" proposed a prevention and cure campaign of rhinogenous deafness in June 2002 in some primary schools in the Colle val D'Elsa district. A sample of 87 children was involved in the study (average age of 5,64 +/- 1,41 years). On entering the thermal baths a questionnaire was administered to the parents, to point out possible risk factors. RESULTS: Among the 87 children, 28 cases of SOM and 21 cases of severe tubal disorder were found. Only 19 cases out of 49 were already known to the parents and only 28 joined the study and were examined for three years consecutively. DISCUSSION: Out of the 35 children examined in 2002, 28 returned to "The Galleraie" for the two following years. They repeated the thermal cure for two years as a preventive measure. At present they are not affected by SOM and during the winters suffered a lower number of infections in the primary airways and took less antibiotics. CONCLUSIONS: Our study focuses on infant school children because of their critical age for linguistic and social development. Early diagnosis and therapy prevent any negative social development.
Asunto(s)
Trastornos de la Articulación/prevención & control , Balneología , Pérdida Auditiva/terapia , Otitis Media con Derrame/complicaciones , Otitis Media Supurativa/complicaciones , Trastornos de la Articulación/etiología , Percepción Auditiva/fisiología , Niño , Desarrollo Infantil , Preescolar , Trompa Auditiva/fisiopatología , Femenino , Pérdida Auditiva/etiología , Pérdida Auditiva/prevención & control , Humanos , Italia/epidemiología , Masculino , Faringitis/complicaciones , Servicios de Salud Escolar , Aislamiento Social/psicología , Percepción del Habla/fisiología , Tonsilitis/complicaciones , Resultado del TratamientoRESUMEN
The objective of this review is to examine the use of short-course antibacterial therapy of group A beta-hemolytic streptococcal (GABHS) pharyngotonsillitis, compared with traditional 10-day therapy. In preparing this paper we reviewed the medical literature of studies comparing 10 days of penicillin with shorter courses of antibacterial therapy. Short-course therapy of 6 days of amoxicillin, 4 to 5 days of cephalosporins, and 5 days of azithromycin was found to be as, or more effective than traditional 10-day penicillin therapy. The benefits of short-course therapy include superior compliance and adherence, lower incidence of adverse effects, less effect on the bacterial flora, improved patient and parent satisfaction, and lower drug costs. In conclusion, short courses of amoxicillin, cephalosporins, and macrolides provide superior or equal efficacy to a 10-day course of penicillin therapy in the treatment of GABHS pharyngotonsillitis.
Asunto(s)
Antibacterianos/uso terapéutico , Faringitis/tratamiento farmacológico , Infecciones Estreptocócicas/tratamiento farmacológico , Streptococcus pyogenes/aislamiento & purificación , Tonsilitis/tratamiento farmacológico , Enfermedad Aguda , Amoxicilina/administración & dosificación , Amoxicilina/uso terapéutico , Antibacterianos/administración & dosificación , Azitromicina/administración & dosificación , Azitromicina/uso terapéutico , Cefalosporinas/administración & dosificación , Cefalosporinas/uso terapéutico , Niño , Humanos , Penicilinas/administración & dosificación , Penicilinas/uso terapéutico , Faringitis/complicaciones , Faringitis/microbiología , Infecciones Estreptocócicas/microbiología , Streptococcus pyogenes/efectos de los fármacos , Tonsilitis/complicaciones , Tonsilitis/microbiologíaRESUMEN
In an observational study involving 10 non-hospital-affiliated physicians, 48 patients between 6 and 73 years of age with symptoms of acute tonsillitis were treated with either a liquid or tablet formulation of a herbal compound of Phytolacca, Guajacum, and Capsicum. More than half of the patients reported marked alleviation of the principal symptom, moderate or severe difficulty in swallowing, within the first 5 days of treatment. Comparable improvements occurred in other outcome measures, including earache, headache, and fatigue. No adverse side effects were reported.
Asunto(s)
Fitoterapia , Extractos Vegetales/uso terapéutico , Plantas Medicinales/uso terapéutico , Tonsilitis/tratamiento farmacológico , Enfermedad Aguda , Adolescente , Adulto , Anciano , Niño , Trastornos de Deglución/tratamiento farmacológico , Trastornos de Deglución/etiología , Dolor de Oído/tratamiento farmacológico , Dolor de Oído/etiología , Fatiga/tratamiento farmacológico , Fatiga/etiología , Femenino , Cefalea/tratamiento farmacológico , Cefalea/etiología , Humanos , Masculino , Persona de Mediana Edad , Tonsilitis/complicacionesRESUMEN
The effect of mesodiencephalic modulation (MDM) on peripheral blood immunocompetent cells during a mixed viral/bacterial infection was studied in 10 patients aged 15 to 35 suffering from acute respiratory diseases complicated by lacunar tonsillitis. Control group consisted of 10 patients aged 16 to 42. A course of MDM consisted of 4-5 daily 10-min sessions. MDM alleviated the course of respiratory diseases complicated by lacunar tonsillitis at the expense of activating body response to inflammation and due to immunomodulating effect of electropulse exposure on lymphocyte subpopulations.
Asunto(s)
Infecciones Bacterianas/inmunología , Diencéfalo/fisiología , Mesencéfalo/fisiología , Enfermedades Respiratorias/inmunología , Virosis/inmunología , Enfermedad Aguda , Adolescente , Adulto , Infecciones Bacterianas/complicaciones , Infecciones Bacterianas/terapia , Relación CD4-CD8 , Linfocitos T CD4-Positivos/inmunología , Terapia por Estimulación Eléctrica , Humanos , Células Asesinas Naturales/inmunología , Enfermedades Respiratorias/complicaciones , Enfermedades Respiratorias/terapia , Tonsilitis/complicaciones , Tonsilitis/inmunología , Tonsilitis/terapia , Virosis/complicaciones , Virosis/terapiaRESUMEN
The therapeutic efficacy of the synthetic immunostimulant pidotimod ((R)-3-[(S)-(5-oxo-2-pyrrolidinyl) carbonyl]-thiazolidine-4-carboxylic acid, PGT/1A, CAS 121808-62-6) was evaluated in a double-blind placebo-controlled study in parallel groups in the management of recurrences in 235 children with recurrent tonsillitis. The ambulant study provided for 15 days of treatment with two oral vials of pidotimod 400 mg or placebo daily, in accordance with a randomisation list, 60 days of treatment with one oral vial of pidotimod 400 mg or placebo daily, and a 90-day follow-up period. The total trial period was 165 days. In addition to evaluating the number of tonsillitis recurrences which occurred during the 75 days of treatment and the 90-day follow-up period, the number of days on which the principal symptoms of the illness were present and on which drugs such as antibiotics or anti-inflammatory agents were used concomitantly, as well as the number of days' absence from school, were analyzed. The findings showed that, taking the treatment phase and the three-month follow-up period together, pidotimod significantly reduces the incidence of inflammatory upper airways episodes. The very low incidence of adverse effects, which was the same as that in the placebo group, confirmed the excellent safety of the product.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Ácido Pirrolidona Carboxílico/análogos & derivados , Tiazoles/uso terapéutico , Tonsilitis/tratamiento farmacológico , Adyuvantes Inmunológicos/efectos adversos , Adolescente , Antibacterianos/uso terapéutico , Antiinflamatorios/uso terapéutico , Niño , Preescolar , Método Doble Ciego , Femenino , Humanos , Masculino , Ácido Pirrolidona Carboxílico/efectos adversos , Ácido Pirrolidona Carboxílico/uso terapéutico , Recurrencia , Tiazoles/efectos adversos , Tiazolidinas , Tonsilitis/complicaciones , Tonsilitis/inmunologíaRESUMEN
A 10-year-old girl had two localized psoriasiform plaques at birth. Subsequently, she developed generalized, asymptomatic, scaly plaques arranged in linear bands and streaks along the lines of Blaschko. The morphologic and histopathologic features, the clinical course, and HLA (CW6,A2) association were characteristic of psoriasis. Although rare, true linear psoriasis exists.
Asunto(s)
Psoriasis/congénito , Niño , Femenino , Antígenos HLA/análisis , Humanos , Terapia PUVA , Psoriasis/tratamiento farmacológico , Psoriasis/patología , Tonsilitis/complicacionesRESUMEN
Clinical and immunological parameters of 77 children with tonsillogenic lesions of the heart were investigated. Taking into consideration the pathogenetic mechanisms of cardiovascular pathologies in children with chronic tonsillitis and their immunity changes, a method of autotransfusion of UV irradiated blood was developed and used for their therapy. Before and after tonsillectomy the patients underwent this autotransfusion in order to accelerate their rehabilitation. It was demonstrated that in patients whose treatment involved autotransfusion, cardiac symptoms disappeared and immunological parameters stabilized faster than in the children given routine treatment.
Asunto(s)
Transfusión de Sangre Autóloga , Sangre/efectos de la radiación , Cardiopatías/rehabilitación , Tonsilitis/complicaciones , Rayos Ultravioleta , Enfermedad Crónica , Cardiopatías/etiología , Cardiopatías/inmunología , Humanos , Tonsilectomía , Tonsilitis/cirugíaRESUMEN
In a double-blind study, 20 patients with peritonsillar abscesses were treated with 2 g phenoxymethylpenicillin b.i.d. for ten days together with needle aspiration, incision and daily drainage, and 20 patients were treated with 2 g phenoxymethylpenicillin b.i.d. and 0.8 g metronidazole b.i.d. for ten days together with needle aspiration, incision and daily drainage. Group A beta-hemolytic streptococci were isolated from pus in 20 of the patients with peritonsillar abscesses, in five of these together with indigenous oropharyngeal aerobic and anaerobic microorganisms. Pure anaerobic bacteria were found in nine abscesses, together with indigenous aerobic microorganisms in eight, and together with group A, C and G streptococci in five. In one patient heavily colonized with beta-lactamase-producing Staphylococcus aureus, Haemophilus parainfluenzae and Bacteroides, group A beta-streptococci failed to be eradicated. In the penicillin group, nine of 18 patients harboured beta-lactamase producing Bacteroides strains in the tonsils on the day of admission. On the third and tenth days of treatment all patients harboured beta-lactamase producing Bacteroides strains in the tonsils, while in the penicillin + metronidazole group, only one out of 17 patients still harboured beta-lactamase producing Bacteroides strains. None of the patients harboured beta-lactamase producing fusobacteria on the day of admission. In the penicillin group, however, beta-lactamase producing fusobacteria were recovered from three patients on the tenth day of treatment. No beta-lactamase producing fusobacteria were recovered from the penicillin + metronidazole group.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Absceso/tratamiento farmacológico , Metronidazol/uso terapéutico , Tonsila Palatina , Penicilina V/uso terapéutico , Absceso/microbiología , Adolescente , Adulto , Bacterias/efectos de los fármacos , Ensayos Clínicos como Asunto , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Tonsila Palatina/microbiología , Distribución Aleatoria , Tonsilitis/complicacionesRESUMEN
As part of a clinical-epidemiological follow-up carried out between 1975 and 1979 in Iasi, the evolution of the clinical and functional recuperatory process in a series of 269 patients with articular rheumatismal manifestations, out of which 67.6% caused by pharyngo-amigdalytis infections, was studied. The investigations on ASLO, fibrinogen, VSH, urinary sediment, ECG and presence of some germs, having etiological significance, in the nasopharyngeal exudate have brought data pleading for the infectious-allergic etiopathogenesis of an important number of the chronic articular rheumatism cases. The drug treatment and balneophysiotherapy had full recuperatory effects in 18.2% and partial ones in 57.6% of the cases. The cost of the recuperatory intervention is about 4-4,500 lei/year/patient.